Primary. Adjunct. Replacement.
SLT has your glaucoma patents covered.

SLT lowers IOP as effectively as medication, has a consistent safety profile, and – best of all – is efficacious at every stage of the glaucoma treatment algorithm. A highly effective primary therapy option, especially in non-compliant patients, SLT can also reduce the number of medications required to control IOP.